Trading Members of the Exchange are hereby informed that the suspension in trading of equity shares of the below mentioned company will be revoked w.e.f. November 27, 2018. Pursuant to SEBI Circular No. CIR/CFD/CMD/12/2015 dated November 30, 2015, trading in the securities of the company will be resumed in “P” group.
|
Scrip Code
|
Name of the Company
|
|
500274
|
Mesco Pharmaceuticals Ltd.
|
Trading members may note that the entire promoter’s shareholding i.e.79,86,100 equity shares are under lock-in as per the details given under:
|
No of Shares
|
Distinctive Nos
|
Date up to – under lock-in
|
|
79,86,100
|
Annexure II
|
February 28, 2019
|
A profile of the Company is also attached as Annexure I.
The Information Memorandum of the aforesaid company will be available on the Exchange’s website under Corporates->Corporate Filings->Information Memorandum->Revocation.
Further the trading members may please note that the above mentioned scrip will be a part of Special Pre-open Session for IPO’s & Relisted Scrips -Relist session on November 27, 2018.
For further information on SPOS, the trading members are requested to refer to the Exchange’s notice no.20120216-29 on Enabling Special Pre-open Session for IPO’s & Relisted Scrips.
Trading Members are requested to take note of the same.
Arpita Joshi Sonali Kurhade
Manager Dy. Manager
Listing Compliance Listing Compliance
November 19, 2018
|